Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET)

Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET) - RESET

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002634

Enrollment

3200

Registered

2009-11-01

Start date

2010-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

XIENCE V stent implantation in 1600 patients CYPHER SELECT+stent implantation in 1600 patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who will be recieved drug-eluting stent

Exclusion criteria

Exclusion criteria: The patients who refuse to participate in this study

Design outcomes

Primary

Measure	Time frame
Any TLR at 1 year Death / MI at 3 years	—

Secondary

Measure	Time frame
Death / MI at 1 year and 2 years Success rate for stent deployment	—

Countries

Japan

Contacts

Public ContactTAMURA TOSHIHIRO

Kyoto University Hospital Department of Cardiovascular Medicine

ttamu@kuhp.kyoto-u.ac.jp075-751-4255

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026